Latest Triple-negative breast cancer Stories
A study conducted at Boston University School of Medicine (BUSM) demonstrates an effective combination therapy for breast cancer cells in vitro.
The Canadian Breast Cancer Foundation – BC/Yukon Region (CBCF) is thrilled to announce a game-changing discovery in triple-negative breast cancer (TNBC).
Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered a potential explanation for why breast cancer is not experienced the
The histone de-acetylase (HDAC) inhibitor panobinostat is able to target and destroy triple negative breast cancer, reveals a new study published in BioMed Central's open access journal Breast Cancer Research.
New findings presented at Europe's leading breast cancer translational research conference this year shed new light on the many biological differences between individual breast cancers.
American women of African ancestry are more likely than European Americans to have estrogen receptor (ER) negative breast cancer.
An international team of scientists, including four at Simon Fraser University, has made a discovery that will change the way the most deadly form of breast cancer is treated.
Scientists have uncovered a marker of DNA damage that could predict who will respond to platinum-based chemotherapy drugs like cisplatin or carboplatin.